Antibody-Drug Conjugates in the Treatment of Metastatic Breast Cancer: The Emerging Questions of Sequence and Resistance

Metastatic breast cancer continues to present significant therapeutic challenges, necessitating ongoing exploration of innovative treatments. The use of antibody-drug conjugates (ADCs) represents an effective treatment strategy that combines the targeting capabilities of monoclonal antibodies with t...

Full description

Bibliographic Details

Published in:	healthbook TIMES. Oncology Hematology
Main Authors:	Allan Relecom, Francesco Sciotto, Mathieu Chevallier, José Luis Sandoval
Format:	Article
Language:	English
Published:	THE HEALTHBOOK COMPANY LTD. 2024-10-01
Online Access:	https://doi.org/10.36000/HBT.OH.2024.21.155